title: Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
abstract: Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
authors.affiliation: Department of Cardiology, Tan Tock Seng Hospital, Singapore.
authors.forename: Pow-Li
authors.initials: PL
authors.lastname: Chia
authors.affiliation: Department of Cardiology, Tan Tock Seng Hospital, Singapore.
authors.forename: David
authors.initials: D
authors.lastname: Foo
mesh_terms: D044466:Asian People; D058406:Cardiac Resynchronization Therapy; D002309:Cardiology; D002986:Clinical Trials as Topic; D016757:Death, Sudden, Cardiac; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D012846:Singapore; D018487:Ventricular Dysfunction, Left / Q000628:therapy
keywords: cardiac implantable electronic devices; cardiac resynchronisation therapy; heart failure; implantable cardioverter defibrillator